Crossmark

Phosphodiesterase inhibitors used in androgenic alopecia as a possible risk factor for testicular tumor

Crossref DOI link: https://doi.org/10.1016/j.medcle.2023.04.004

Published Print: 2023-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Sainz Ramírez, María

García Robles, Rubén

Salguero Molpeceres, Oliver Luis
License Information

Text and Data Mining valid from 2023-05-01
More Information

This article is maintained by: Elsevier

Article Title: Phosphodiesterase inhibitors used in androgenic alopecia as a possible risk factor for testicular tumor

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2023.04.004

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2022.12.010

Content Type: simple-article

Copyright: © 2022 Elsevier España, S.L.U. All rights reserved.